Pilot study of liraglutide effects in non-alcoholic steatohepatitis and non-alcoholic fatty liver disease with glucose intolerance in Japanese patients (LEAN-J)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pilot study of liraglutide effects in non-alcoholic steatohepatitis and non-alcoholic fatty liver disease with glucose intolerance in Japanese patients (LEAN-J)

Published:2014-05-28 Issue:3 Volume:45 Page:269-278
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Eguchi Yuichiro¹,Kitajima Yoichiro²³,Hyogo Hideyuki⁴,Takahashi Hirokazu²,Kojima Motoyasu²,Ono Masafumi⁵,Araki Norimasa³,Tanaka Kenichi³,Yamaguchi Miyuki²,Matsuda Yayoi²,Ide Yasushi²,Otsuka Taiga²,Ozaki Iwata²,Ono Naofumi³,Eguchi Takahisa³,Anzai Keizo²,

Affiliation:

1. Division of Hepatology; Saga Medical School; Saga Japan

2. Department of Internal Medicine; Saga Medical School; Saga Japan

3. Clinical Gastroenterology; Eguchi Hospital; Saga Japan

4. Department of Medicine and Molecular Science; Graduate School of Biomedical Sciences; Hiroshima University; Hiroshima Japan

5. Department of Gastroenterology and Hepatology; Kochi Medical School; Kochi Japan

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hepr.12351/fullpdf

Reference53 articles.

1. Nonalcoholic fatty liver disease;Angulo;N Engl J Med,2002

2. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference;Neuschwander-Tetri;Hepatology,2003

3. Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis;Promrat;Hepatology,2010

4. Non-alcoholic fatty liver disease from pathogenesis to management: an update;Musso;Obes Rev,2010

5. A pilot trial of body weight reduction for nonalcoholic fatty liver disease with a home-based lifestyle modification intervention delivered in collaboration with interdisciplinary medical staff;Oza;J Gastroenterol,2009

Cited by 160 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decreasing the burden of non-alcoholic fatty liver disease: From therapeutic targets to drug discovery opportunities;European Journal of Medicinal Chemistry;2024-11

2. Glucagon-like peptide-1 (GLP-1) receptor agonists for weight management: A review for the gynecologic oncologist;Gynecologic Oncology;2024-11

3. Clinical Efficacy and Body Composition Changes with Sodium Glucose Cotransporter 2 Inhibitor/Glucagon-like Peptide-1 Antagonist Combination Therapy in Patients with Type 2 Diabetes Mellitus-associated Nonalcoholic Fatty Liver Disease;Internal Medicine;2024-09-15

4. The role of glucagon-like peptide-1 receptor agonists (GLP1-RAs) in the management of the hypertensive patient with metabolic syndrome: a position paper from the Korean society of hypertension;Clinical Hypertension;2024-09-01

5. Modern Management of Cardiometabolic Continuum: From Overweight/Obesity to Prediabetes/Type 2 Diabetes Mellitus. Recommendations from the Eastern and Southern Europe Diabetes and Obesity Expert Group;Diabetes Therapy;2024-07-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3